SG Americas Securities’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $847K | Buy |
|
|||||
|
2025
Q2 | $120K | Sell |
|
|||||
|
2025
Q1 | $301K | Sell |
|
|||||
|
2024
Q4 | $45.6M | Buy |
|
|||||
|
2024
Q3 | $7.95M | Buy |
|
|||||
|
2024
Q2 | $1.62M | Buy |
|
|||||
|
2024
Q1 | $1.57M | Buy |
|
|||||
|
2023
Q4 | $767K | Sell |
|
|||||
|
2023
Q3 | $1.51M | Buy |
|
|||||
|
2023
Q2 | $125K | Sell |
|
|||||
|
2023
Q1 | $2.86M | Buy |
|
|||||
|
2022
Q4 | $224K | Sell |
|
|||||
|
2022
Q3 | $392K | Sell |
|
|||||
|
2022
Q2 | $1.01M | Buy |
|
|||||
|
2022
Q1 | $157K | Sell |
|
|||||
|
2021
Q4 | $586K | Sell |
|
|||||
|
2021
Q3 | $1.02M | Buy |
|
|||||
|
2021
Q2 | $359K | Buy |
|
|||||
|
2021
Q1 | $198K | Buy |
|
|||||
|
2020
Q4 | $269K | Sell |
|
|||||
|
2020
Q3 | $350K | Buy |
|
|||||
|
2020
Q2 | $396K | Sell |
|
|||||
|
2020
Q1 | $1.17M | Buy |
|
|||||
|
2019
Q4 | $915K | Sell |
|
|||||
|
2019
Q3 | $810K | Buy |
|
|||||
|
2019
Q2 | $196K | Sell |
|
|||||
|
2019
Q1 | $283K | Sell |
|
|||||
|
2018
Q4 | $254K | Buy |
|
|||||
|
2018
Q3 | $290K | Buy |
|
|||||
|
2018
Q2 | $145K | Sell |
|
|||||
|
2018
Q1 | $656K | Sell |
|
|||||
|
2017
Q4 | $1.93M | Buy |
|
|||||
|
2017
Q3 | $164K | Sell |
|
|||||
|
2017
Q2 | $202K | Sell |
|
|||||
|
2017
Q1 | $387K | Sell |
|
|||||
|
2016
Q4 | $1.93M | Buy |
|
|||||
|
2016
Q3 | $416K | Buy |
|
|||||
|
2016
Q2 | $406K | Buy |
|
|||||
|
2016
Q1 | $316K | Buy |
|
|||||
|
2015
Q4 | $342K | Sell |
|
|||||
|
2015
Q3 | $600K | Buy |
|
|||||
|
2015
Q2 | $219K | Sell |
|
|||||
|
2015
Q1 | $320K | Sell |
|
|||||
|
2014
Q4 | $824K | Buy |
|
|||||
|
2014
Q3 | $363K | Buy |
|
|||||
|
2014
Q2 | $233K | Buy |
|
|||||
|
2014
Q1 | $122K | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $397K | Buy |
|